Migraine Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with migraine (with or without aura) according to recognised international headache diagnostic standards
- People who experience fewer than 8 migraine days per month
- People who are able to read, write, and understand instructions
- People who have access to the internet and an email address
- People who are willing to sign a consent form agreeing to take part
Who may not be able to join:
- People who are currently taking preventive (ongoing) medication specifically for migraine
- People who are currently taking any medication that affects the central nervous system (brain and spinal cord)
- People who have a serious physical or mental health condition
- People who have a heart, blood vessel, or liver disease
- People who are pregnant or breastfeeding
- People for whom triptan medications (a common type of migraine treatment) are not medically suitable
- People who experience severe migraine attacks that have not previously responded to triptans or anti-inflammatory pain relievers such as ibuprofen
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Marta Torres-Ferrús, PhD, Hospital Universitari Vall d'Hebron, Headache & Neurological Pain Research Group
Phone: (+34)934893000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Response to sumatriptan
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.